Heart failure in COVID-19: the multicentre, multinational PCHF-COVICAV registry.
Mateusz SokolskiSander TrensonJustyna Maria SokolskaDomenico D'AmarioPhilippe MeyerNana K PokuTor Biering-SørensenMats C Højbjerg LassenKristoffer G SkaarupEduardo Barge-CaballeroAnne-Catherine PouleurDavide StolfoGianfranco SinagraKlemens AblasserViktoria MusterPeter P RainerMarkus WallnerAlessandra ChiodiniPascal S HeinigerFran MikulicicJudith SchwaigerStephan WinnikHuseyin A CakmakMargherita GaudenziMassimo MapelliIrene MattavelliMatthias PaulIrina Cabac-PogoreviciClaire BouletiMarzia LilliuChiara MinoiaJeroen DauwJérôme CostaAhmet CelikNathan MewtonCarlos E L MontenegroYuya MatsueGoran LoncarMichal MarchelAris BechlioulisLampros MichalisMarcus DörrEdgard PrihadiFelix SchoenrathDaniel R MessroghliWilfried MullensLars H LundGiuseppe M C RosanoPiotr PonikowskiFrank RuschitzkaAndreas J FlammerPublished in: ESC heart failure (2021)
Hospitalized COVID-19 patients with HF are at increased risk for in-hospital death. In-hospital worsening of HF or acute HF de novo are common and associated with a further increase in in-hospital mortality.
Keyphrases
- coronavirus disease
- acute heart failure
- sars cov
- heart failure
- healthcare
- liver failure
- acute care
- adverse drug
- clinical trial
- respiratory failure
- study protocol
- left ventricular
- cross sectional
- drug induced
- atrial fibrillation
- randomized controlled trial
- intensive care unit
- aortic dissection
- extracorporeal membrane oxygenation